 | • レポートコード：QYR9ST03621 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、糖尿病性網膜症の治療の世界市場について調査・分析し、糖尿病性網膜症の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（増殖性糖尿病性網膜症（PDR）、非増殖性糖尿病性網膜症（NPDR））、用途別（眼科クリニック、外来手術センター、病院、その他のエンドユーザー）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の糖尿病性網膜症の治療市場動向 ・主要企業別マーケットシェア ・糖尿病性網膜症の治療の種類別市場規模2014-2019 （増殖性糖尿病性網膜症（PDR）、非増殖性糖尿病性網膜症（NPDR）） ・糖尿病性網膜症の治療の用途別市場規模2014-2019 （眼科クリニック、外来手術センター、病院、その他のエンドユーザー） ・糖尿病性網膜症の治療の北米市場：主要企業・種類別/用途別市場規模 ・糖尿病性網膜症の治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・糖尿病性網膜症の治療の中国市場：主要企業・種類別/用途別市場規模 ・糖尿病性網膜症の治療の日本国内市場：主要企業・種類別/用途別市場規模 ・糖尿病性網膜症の治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・糖尿病性網膜症の治療のインド市場：主要企業・種類別/用途別市場規模 ・糖尿病性網膜症の治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Regeneron Pharmaceuticals、ThromboGenics、Genentech、Bayer Healthcare、Alimera Sciences、Actavis、BCN Peptides、Novartis、Ampio Pharmaceuticals、Kowa Group、Sirnaomicsorporation、Abbott Laboratories、Glycadia Pharmaceuticals、Alcon Laboratories、Parexel International） ・糖尿病性網膜症の治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Diabetic retinopathy (die-uh-BET-ik ret-ih-NOP-uh-thee) is a diabetes complication that affects eyes. It’s caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina).In 2018, the global Diabetic Retinopathy Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Diabetic Retinopathy Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetic Retinopathy Treatment development in United States, Europe and China.
The key players covered in this study
Regeneron Pharmaceuticals
ThromboGenics
Genentech
Bayer Healthcare
Alimera Sciences
Actavis
BCN Peptides
Novartis
Ampio Pharmaceuticals
Kowa Group
Sirnaomicsorporation
Abbott Laboratories
Glycadia Pharmaceuticals
Alcon Laboratories
Parexel International
Market segment by Type, the product can be split into
Proliferative Diabetic Retinopathy (PDR)
Non-Proliferative Diabetic Retinopathy (NPDR)
Market segment by Application, split into
Ophthalmic Clinics
Ambulatory Surgical Centers
Hospitals
Other End Users
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Diabetic Retinopathy Treatment status, future forecast, growth opportunity, key market and key players.
To present the Diabetic Retinopathy Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Diabetic Retinopathy Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Diabetic Retinopathy Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Proliferative Diabetic Retinopathy (PDR)
1.4.3 Non-Proliferative Diabetic Retinopathy (NPDR)
1.5 Market by Application
1.5.1 Global Diabetic Retinopathy Treatment Market Share by Application (2014-2025)
1.5.2 Ophthalmic Clinics
1.5.3 Ambulatory Surgical Centers
1.5.4 Hospitals
1.5.5 Other End Users
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Diabetic Retinopathy Treatment Market Size
2.2 Diabetic Retinopathy Treatment Growth Trends by Regions
2.2.1 Diabetic Retinopathy Treatment Market Size by Regions (2014-2025)
2.2.2 Diabetic Retinopathy Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Diabetic Retinopathy Treatment Market Size by Manufacturers
3.1.1 Global Diabetic Retinopathy Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Diabetic Retinopathy Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Diabetic Retinopathy Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Diabetic Retinopathy Treatment Key Players Head office and Area Served
3.3 Key Players Diabetic Retinopathy Treatment Product/Solution/Service
3.4 Date of Enter into Diabetic Retinopathy Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Diabetic Retinopathy Treatment Market Size by Type (2014-2019)
4.2 Global Diabetic Retinopathy Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Diabetic Retinopathy Treatment Market Size (2014-2019)
5.2 Diabetic Retinopathy Treatment Key Players in United States
5.3 United States Diabetic Retinopathy Treatment Market Size by Type
5.4 United States Diabetic Retinopathy Treatment Market Size by Application
6 Europe
6.1 Europe Diabetic Retinopathy Treatment Market Size (2014-2019)
6.2 Diabetic Retinopathy Treatment Key Players in Europe
6.3 Europe Diabetic Retinopathy Treatment Market Size by Type
6.4 Europe Diabetic Retinopathy Treatment Market Size by Application
7 China
7.1 China Diabetic Retinopathy Treatment Market Size (2014-2019)
7.2 Diabetic Retinopathy Treatment Key Players in China
7.3 China Diabetic Retinopathy Treatment Market Size by Type
7.4 China Diabetic Retinopathy Treatment Market Size by Application
8 Japan
8.1 Japan Diabetic Retinopathy Treatment Market Size (2014-2019)
8.2 Diabetic Retinopathy Treatment Key Players in Japan
8.3 Japan Diabetic Retinopathy Treatment Market Size by Type
8.4 Japan Diabetic Retinopathy Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Diabetic Retinopathy Treatment Market Size (2014-2019)
9.2 Diabetic Retinopathy Treatment Key Players in Southeast Asia
9.3 Southeast Asia Diabetic Retinopathy Treatment Market Size by Type
9.4 Southeast Asia Diabetic Retinopathy Treatment Market Size by Application
10 India
10.1 India Diabetic Retinopathy Treatment Market Size (2014-2019)
10.2 Diabetic Retinopathy Treatment Key Players in India
10.3 India Diabetic Retinopathy Treatment Market Size by Type
10.4 India Diabetic Retinopathy Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Diabetic Retinopathy Treatment Market Size (2014-2019)
11.2 Diabetic Retinopathy Treatment Key Players in Central & South America
11.3 Central & South America Diabetic Retinopathy Treatment Market Size by Type
11.4 Central & South America Diabetic Retinopathy Treatment Market Size by Application
12 International Players Profiles
12.1 Regeneron Pharmaceuticals
12.1.1 Regeneron Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Diabetic Retinopathy Treatment Introduction
12.1.4 Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Treatment Business (2014-2019)
12.1.5 Regeneron Pharmaceuticals Recent Development
12.2 ThromboGenics
12.2.1 ThromboGenics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Diabetic Retinopathy Treatment Introduction
12.2.4 ThromboGenics Revenue in Diabetic Retinopathy Treatment Business (2014-2019)
12.2.5 ThromboGenics Recent Development
12.3 Genentech
12.3.1 Genentech Company Details
12.3.2 Company Description and Business Overview
12.3.3 Diabetic Retinopathy Treatment Introduction
12.3.4 Genentech Revenue in Diabetic Retinopathy Treatment Business (2014-2019)
12.3.5 Genentech Recent Development
12.4 Bayer Healthcare
12.4.1 Bayer Healthcare Company Details
12.4.2 Company Description and Business Overview
12.4.3 Diabetic Retinopathy Treatment Introduction
12.4.4 Bayer Healthcare Revenue in Diabetic Retinopathy Treatment Business (2014-2019)
12.4.5 Bayer Healthcare Recent Development
12.5 Alimera Sciences
12.5.1 Alimera Sciences Company Details
12.5.2 Company Description and Business Overview
12.5.3 Diabetic Retinopathy Treatment Introduction
12.5.4 Alimera Sciences Revenue in Diabetic Retinopathy Treatment Business (2014-2019)
12.5.5 Alimera Sciences Recent Development
12.6 Actavis
12.6.1 Actavis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Diabetic Retinopathy Treatment Introduction
12.6.4 Actavis Revenue in Diabetic Retinopathy Treatment Business (2014-2019)
12.6.5 Actavis Recent Development
12.7 BCN Peptides
12.7.1 BCN Peptides Company Details
12.7.2 Company Description and Business Overview
12.7.3 Diabetic Retinopathy Treatment Introduction
12.7.4 BCN Peptides Revenue in Diabetic Retinopathy Treatment Business (2014-2019)
12.7.5 BCN Peptides Recent Development
12.8 Novartis
12.8.1 Novartis Company Details
12.8.2 Company Description and Business Overview
12.8.3 Diabetic Retinopathy Treatment Introduction
12.8.4 Novartis Revenue in Diabetic Retinopathy Treatment Business (2014-2019)
12.8.5 Novartis Recent Development
12.9 Ampio Pharmaceuticals
12.9.1 Ampio Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Diabetic Retinopathy Treatment Introduction
12.9.4 Ampio Pharmaceuticals Revenue in Diabetic Retinopathy Treatment Business (2014-2019)
12.9.5 Ampio Pharmaceuticals Recent Development
12.10 Kowa Group
12.10.1 Kowa Group Company Details
12.10.2 Company Description and Business Overview
12.10.3 Diabetic Retinopathy Treatment Introduction
12.10.4 Kowa Group Revenue in Diabetic Retinopathy Treatment Business (2014-2019)
12.10.5 Kowa Group Recent Development
12.11 Sirnaomicsorporation
12.12 Abbott Laboratories
12.13 Glycadia Pharmaceuticals
12.14 Alcon Laboratories
12.15 Parexel International
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Diabetic Retinopathy Treatment Key Market Segments
Table Key Players Diabetic Retinopathy Treatment Covered
Table Global Diabetic Retinopathy Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Diabetic Retinopathy Treatment Market Size Market Share by Type 2014-2025
Figure Proliferative Diabetic Retinopathy (PDR) Figures
Table Key Players of Proliferative Diabetic Retinopathy (PDR)
Figure Non-Proliferative Diabetic Retinopathy (NPDR) Figures
Table Key Players of Non-Proliferative Diabetic Retinopathy (NPDR)
Table Global Diabetic Retinopathy Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Ophthalmic Clinics Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Hospitals Case Studies
Figure Other End Users Case Studies
Figure Diabetic Retinopathy Treatment Report Years Considered
Table Global Diabetic Retinopathy Treatment Market Size 2014-2025 (Million US$)
Figure Global Diabetic Retinopathy Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Diabetic Retinopathy Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Diabetic Retinopathy Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Diabetic Retinopathy Treatment Market Share by Regions 2014-2019
Figure Global Diabetic Retinopathy Treatment Market Share by Regions 2014-2019
Figure Global Diabetic Retinopathy Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Diabetic Retinopathy Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Diabetic Retinopathy Treatment Market Share by Manufacturers (2014-2019)
Figure Global Diabetic Retinopathy Treatment Market Share by Manufacturers in 2018
Table Global Diabetic Retinopathy Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Diabetic Retinopathy Treatment Product/Solution/Service
Table Date of Enter into Diabetic Retinopathy Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Diabetic Retinopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Diabetic Retinopathy Treatment Market Size Share by Type (2014-2019)
Figure Global Diabetic Retinopathy Treatment Market Size Market Share by Type (2014-2019)
Table Global Diabetic Retinopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Diabetic Retinopathy Treatment Market Size Share by Application (2014-2019)
Figure Global Diabetic Retinopathy Treatment Market Size Market Share by Application (2014-2019)
Figure Global Diabetic Retinopathy Treatment Revenue Market Share by Application in 2018
Figure United States Diabetic Retinopathy Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Diabetic Retinopathy Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Diabetic Retinopathy Treatment Market Share (2018-2019)
Table United States Diabetic Retinopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Diabetic Retinopathy Treatment Market Share by Type (2014-2019)
Table United States Diabetic Retinopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Diabetic Retinopathy Treatment Market Share by Application (2014-2019)
Figure Europe Diabetic Retinopathy Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Diabetic Retinopathy Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Diabetic Retinopathy Treatment Market Share (2018-2019)
Table Europe Diabetic Retinopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Diabetic Retinopathy Treatment Market Share by Type (2014-2019)
Table Europe Diabetic Retinopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Diabetic Retinopathy Treatment Market Share by Application (2014-2019)
Figure China Diabetic Retinopathy Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Diabetic Retinopathy Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Diabetic Retinopathy Treatment Market Share (2018-2019)
Table China Diabetic Retinopathy Treatment Market Size by Type (2014-20189) (Million US$)
Table China Diabetic Retinopathy Treatment Market Share by Type (2014-2019)
Table China Diabetic Retinopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table China Diabetic Retinopathy Treatment Market Share by Application (2014-2019)
Figure Japan Diabetic Retinopathy Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Diabetic Retinopathy Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Diabetic Retinopathy Treatment Market Share (2018-2019)
Table Japan Diabetic Retinopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Diabetic Retinopathy Treatment Market Share by Type (2014-2019)
Table Japan Diabetic Retinopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Diabetic Retinopathy Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Diabetic Retinopathy Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Diabetic Retinopathy Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Diabetic Retinopathy Treatment Market Share (2018-2019)
Table Southeast Asia Diabetic Retinopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Diabetic Retinopathy Treatment Market Share by Type (2014-2019)
Table Southeast Asia Diabetic Retinopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Diabetic Retinopathy Treatment Market Share by Application (2014-2019)
Figure India Diabetic Retinopathy Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Diabetic Retinopathy Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Diabetic Retinopathy Treatment Market Share (2018-2019)
Table India Diabetic Retinopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table India Diabetic Retinopathy Treatment Market Share by Type (2014-2019)
Table India Diabetic Retinopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table India Diabetic Retinopathy Treatment Market Share by Application (2014-2019)
Figure Central & South America Diabetic Retinopathy Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Diabetic Retinopathy Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Diabetic Retinopathy Treatment Market Share (2018-2019)
Table Central & South America Diabetic Retinopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Diabetic Retinopathy Treatment Market Share by Type (2014-2019)
Table Central & South America Diabetic Retinopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Diabetic Retinopathy Treatment Market Share by Application (2014-2019)
Table Regeneron Pharmaceuticals Company Details
Table Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Treatment Business (2014-2019) (Million US$)
Figure Regeneron Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2014-2019)
Table Regeneron Pharmaceuticals Recent Development
Table ThromboGenics Company Details
Table ThromboGenics Revenue in Diabetic Retinopathy Treatment Business (2014-2019)(Million US$)
Figure ThromboGenics Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2014-2019)
Table ThromboGenics Recent Development
Table Genentech Company Details
Table Genentech Revenue in Diabetic Retinopathy Treatment Business (2014-2019)(Million US$)
Figure Genentech Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2014-2019)
Table Genentech Recent Development
Table Bayer Healthcare Company Details
Table Bayer Healthcare Revenue in Diabetic Retinopathy Treatment Business (2014-2019)(Million US$)
Figure Bayer Healthcare Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2014-2019)
Table Bayer Healthcare Recent Development
Table Alimera Sciences Company Details
Table Alimera Sciences Revenue in Diabetic Retinopathy Treatment Business (2014-2019)(Million US$)
Figure Alimera Sciences Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2014-2019)
Table Alimera Sciences Recent Development
Table Actavis Company Details
Table Actavis Revenue in Diabetic Retinopathy Treatment Business (2014-2019)(Million US$)
Figure Actavis Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2014-2019)
Table Actavis Recent Development
Table BCN Peptides Company Details
Table BCN Peptides Revenue in Diabetic Retinopathy Treatment Business (2014-2019)(Million US$)
Figure BCN Peptides Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2014-2019)
Table BCN Peptides Recent Development
Table Novartis Company Details
Table Novartis Revenue in Diabetic Retinopathy Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2014-2019)
Table Novartis Recent Development
Table Ampio Pharmaceuticals Company Details
Table Ampio Pharmaceuticals Revenue in Diabetic Retinopathy Treatment Business (2014-2019)(Million US$)
Figure Ampio Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2014-2019)
Table Ampio Pharmaceuticals Recent Development
Table Kowa Group Company Details
Table Kowa Group Revenue in Diabetic Retinopathy Treatment Business (2014-2019)(Million US$)
Figure Kowa Group Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2014-2019)
Table Kowa Group Recent Development
Table Sirnaomicsorporation Company Details
Table Abbott Laboratories Company Details
Table Glycadia Pharmaceuticals Company Details
Table Alcon Laboratories Company Details
Table Parexel International Company Details
Table Global Diabetic Retinopathy Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Diabetic Retinopathy Treatment Market Size Share by Regions (2019-2025)
Figure Global Diabetic Retinopathy Treatment Market Size Share by Regions in 2025
Figure United States Diabetic Retinopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Diabetic Retinopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Diabetic Retinopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Diabetic Retinopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Diabetic Retinopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Diabetic Retinopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Diabetic Retinopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Diabetic Retinopathy Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Diabetic Retinopathy Treatment Market Size by Product (2019-2025)
Figure Global Diabetic Retinopathy Treatment Market Size by Product in 2025
Table Global Diabetic Retinopathy Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Diabetic Retinopathy Treatment Market Size by Application (2019-2025)
Figure Global Diabetic Retinopathy Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
糖尿病性網膜症の世界市場：市場規模・現状・予測 Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabe…- 黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬の世界市場：市場規模・現状・予測 Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which b…
- 糖尿病性神経障害の治療の世界市場：市場規模・現状・予測 Diabetic neuropathy is a nerve damaging disorder associated with diabetes mellitus. Patients suffering from diabetes since a long time are prone to nerve damages throughout the body, as the symptoms of diabetic neuropathies cannot be diagnosed at an earlier stage.Although there is no cure for diabet…
- 糖尿病性胃不全麻痺の治療の世界市場：市場規模・現状・予測 Delayed gastric emptying associated with diabetes is known as Diabetic Gastroparesis (DGP). Though it occurs in patients suffering from both Type-1 and Type- 2 diabetes, it is more common in female patients suffering from Type-2 diabetes. The cause of DGP is inherent damage in the vagus nerve that c…
- 糖尿病性潰瘍の治療の世界市場：市場規模・現状・予測 Diabetic foot ulcer is a major complication of diabetes mellitus, and probably the major component of the diabetic foot.In 2018, the global Diabetic Ulcers Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. Thi…